FDA Inspection 814565 — Southern Illinois Healthcare

Southern Illinois Healthcare — FEI 1470247

The FDA completed an inspection of Southern Illinois Healthcare on January 17, 2013 in Herrin, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 17, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Herrin, IL (United States)